After radiation, CD44+/CD24− BCSCs isolated from established breast cancer cell lines and primary culture of patient breast cancer cells presented high ATM signaling activity, and treatment with an ATM inhibitor resensitized these cells to radiation [89]. This evidence concerns the gene CD44 and breast carcinoma.